Internal Medicine, Section of Nutrition, Istituto Scientifico San Raffaele, Milano, Italy.
Int J Cardiol. 2012 Jan 26;154(2):111-5. doi: 10.1016/j.ijcard.2010.09.010. Epub 2010 Oct 5.
This study was performed to assess left ventricular (LV) energy metabolism and function in patients with type 1 diabetes with or without overt microvascular complications.
We performed cardiac Magnetic Resonance Imaging (MRI) and (31)P spectroscopy (MRS) in 24 patients with overt microvascular complications and in 15 carefully selected patients without complications in spite of a long duration of the disease (>20 years) and matched for anthropometric features. 31 healthy subjects served as a control group.
Systolic function was preserved in all study subjects. Patients with overt complications showed a higher LV wall mass/end diastolic volume ratio and altered parameters of diastolic function when compared to patients without complications and to controls. They were also characterized by lower PCr/ATP ratio (a recognized marker of energy metabolism). No effect of HbA1c was detected within groups.
In patients with type 1 diabetes 1) overt microvascular complications were associated with altered LV geometry, diastolic function and energy metabolism 2) in patients without complications and duration of disease >20 years no association with these alterations were found despite poor glycemic control. The features of this highly selected subgroup of patients demonstrated that long lasting chronic hyperglycemia per se is not sufficient to induce abnormality of cardiac energy metabolism and that additional yet to be identified (metabolic or genetic) factors must be important contributing factors.
本研究旨在评估 1 型糖尿病患者(有无显性微血管并发症)的左心室(LV)能量代谢和功能。
我们对 24 例显性微血管并发症患者和 15 例精心挑选的无并发症患者(尽管疾病持续时间>20 年,且匹配人体测量特征)进行心脏磁共振成像(MRI)和(31)磷谱(MRS)检查。31 名健康受试者作为对照组。
所有研究对象的收缩功能均正常。与无并发症患者和对照组相比,显性并发症患者的 LV 壁质量/舒张末期容积比更高,舒张功能参数也发生了改变。他们还表现出较低的 PCr/ATP 比值(公认的能量代谢标志物)。组内未检测到 HbA1c 的影响。
在 1 型糖尿病患者中:1)显性微血管并发症与 LV 几何形状、舒张功能和能量代谢改变有关;2)在无并发症和疾病持续时间>20 年的患者中,尽管血糖控制不佳,但未发现这些改变与并发症之间存在关联。这些高度选择的患者亚组的特征表明,长期慢性高血糖本身不足以导致心脏能量代谢异常,而其他尚未确定的(代谢或遗传)因素必须是重要的促成因素。